Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Graham Lappin

Bioanalysis

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioanalysis|April 1, 2015
A historical perspective on radioisotopic tracers in metabolism and biochemistryGraham Lappin
Bioanalysis|November 19, 2010
Microdosing: current and the futureGraham Lappin
Bioanalysis|November 19, 2010
Addressing metabolite safety during first-in-man studies using ¹⁴C-labeled drug and accelerator mass spectrometryGraham Lappin, Mark Seymour
Bioanalysis|November 19, 2010
New ultrasensitive detection technologies and techniques for use in microdosing studiesGraham Lappin, Claudia C Wagner, Oliver Langer, et al.
Bioanalysis|February 23, 2011
AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administrationGraham Lappin, Mark Seymour, Graeme Young, et al.
Bioanalysis|February 23, 2011
An AMS method to determine analyte recovery from pharmacokinetic studies with concomitant extravascular and intravenous administrationGraham Lappin, Mark Seymour, Graeme Young, et al.
Bioanalysis|March 8, 2012
Meeting the MIST regulations: human metabolism in Phase I using AMS and a tiered bioanalytical approachGraham Lappin, Mark Seymour, Gerhard Gross, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioanalysis|April 1, 2015
A historical perspective on radioisotopic tracers in metabolism and biochemistryGraham Lappin
Bioanalysis|November 19, 2010
Microdosing: current and the futureGraham Lappin
Bioanalysis|November 19, 2010
Addressing metabolite safety during first-in-man studies using ¹⁴C-labeled drug and accelerator mass spectrometryGraham Lappin, Mark Seymour
Bioanalysis|November 19, 2010
New ultrasensitive detection technologies and techniques for use in microdosing studiesGraham Lappin, Claudia C Wagner, Oliver Langer, et al.
Bioanalysis|February 23, 2011
AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administrationGraham Lappin, Mark Seymour, Graeme Young, et al.
Bioanalysis|February 23, 2011
An AMS method to determine analyte recovery from pharmacokinetic studies with concomitant extravascular and intravenous administrationGraham Lappin, Mark Seymour, Graeme Young, et al.
Bioanalysis|March 8, 2012
Meeting the MIST regulations: human metabolism in Phase I using AMS and a tiered bioanalytical approachGraham Lappin, Mark Seymour, Gerhard Gross, et al.
Pageof 1